Trelleborg’s Healthcare & Medical team will be exhibiting advanced polymer solutions for healthcare and medical applications at MD&M West in Booth #2601. The company will also showcase its latest capability to help healthcare and medical customers expedite new product development processes.
“This service will accelerate our customers’ time to market and help them achieve their mission of improving patients’ lives,” explained Linda Muroski, president of Trelleborg Global Healthcare & Medical and Marketing Americas, in a news release. “Using our deep knowledge of polymer materials, excellence in manufacturing, and engineering expertise, this new capability will deliver increased value to our customers.”
Trelleborg will also highlight its specialty extruded tubing and hose products. Tubing is available in a full range of sizes and can be custom designed to meet individual application needs.
“We engineer novel extrusion solutions for our customers’ specific tube and hosing applications,” shared Andrew Gaillard, global director of Trelleborg Healthcare & Medical. “Examples include multi-lumen, silicone foam extrusions, and kink-resistant tubing for a variety of critical applications such as pacemaker and neuromodulation leads and urological implants. Additionally, Trelleborg’s GeoTrans technology enables the production of extrusion profiles that can change throughout the length of the extrusion, supporting unique, customer-specific designs.”
The company will also showcase its custom-produced silicone and thermoplastic molded parts made with tight tolerances as well as its advancements in multicomponent and micromolding capabilities.
Explained Gaillard: “One of our most well accepted capabilities is the combination of Liquid Silicone Rubber (LSR) with plastics. Commonly referred to as 2C or 2-shot, multicomponent injection molding allows our LSR experts to employ highly sophisticated tool and process engineering to develop innovative solutions that combine two or more individual materials into one fully bonded, robust component.”
Trelleborg will also share its silicone sheeting and drug delivery capabilities.
“In recent years, we’ve seen a spike in demand from our customer-partners for devices that incorporate an active pharmaceutical ingredient for targeted delivery of a therapy. Whether challenged with a wound-care application that requires wafer-thin silicone gel films with a drug element incorporated, or an innovative approach to cancer treatment with unique manufacturing challenges, our engineering teams are consistently eager to partner with customers to help solve interesting and complex problems,” stated Gaillard.